Literature DB >> 23486760

Targeting the PyMT Oncogene to Diverse Mammary Cell Populations Enhances Tumor Heterogeneity and Generates Rare Breast Cancer Subtypes.

Brittni A Smith1, Dawne N Shelton, Collin Kieffer, Brett Milash, Jerry Usary, Charles M Perou, Philip S Bernard, Bryan E Welm.   

Abstract

Human breast cancer is a heterogeneous disease composed of different histologies and molecular subtypes, many of which are not replicated in animal models. Here, we report a mouse model of breast cancer that generates unique tumor histologies including tubular, adenosquamous, and lipid-rich carcinomas. Utilizing a nononcogenic variant of polyoma middle T oncogene (PyMT) that requires a spontaneous base-pair deletion to transform cells, in conjunction with lentiviral transduction and orthotopic transplantation of primary mammary epithelial cells, this model sporadically induces oncogene expression in both the luminal and myoepithelial cell lineages of the normal mouse mammary epithelium. Microarray and hierarchical analyses using an intrinsic subtype gene set revealed that lentiviral PyMT generates both luminal and basal-like tumors. Cumulatively, these results show that low-level expression of PyMT in a broad range of cell types significantly increases tumor heterogeneity and establishes a mouse model of several rare human breast cancer subtypes.

Entities:  

Keywords:  PyMT; breast cancer; cell of origin; lipid rich; mammary gland

Year:  2012        PMID: 23486760      PMCID: PMC3591097          DOI: 10.1177/1947601913475359

Source DB:  PubMed          Journal:  Genes Cancer        ISSN: 1947-6019


  55 in total

1.  Gene ontology: tool for the unification of biology. The Gene Ontology Consortium.

Authors:  M Ashburner; C A Ball; J A Blake; D Botstein; H Butler; J M Cherry; A P Davis; K Dolinski; S S Dwight; J T Eppig; M A Harris; D P Hill; L Issel-Tarver; A Kasarskis; S Lewis; J C Matese; J E Richardson; M Ringwald; G M Rubin; G Sherlock
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

2.  Cellular ras gene activity is required for full neoplastic transformation by polyomavirus.

Authors:  L Raptis; R Marcellus; M J Corbley; A Krook; J Whitfield; S K Anderson; T Haliotis
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

3.  Mammary lipid-rich carcinoma with extensive amyloid deposition in a dog.

Authors:  Meina Tei; Kazuyuki Uchida; James K Chambers; Hiromi Harada; Masashi Takahashi; Ryohei Nishimura; Manabu Watanabe; Hiroyuki Nakayama
Journal:  J Vet Med Sci       Date:  2012-01-20       Impact factor: 1.267

4.  The life history of 21 breast cancers.

Authors:  Serena Nik-Zainal; Peter Van Loo; David C Wedge; Ludmil B Alexandrov; Christopher D Greenman; King Wai Lau; Keiran Raine; David Jones; John Marshall; Manasa Ramakrishna; Adam Shlien; Susanna L Cooke; Jonathan Hinton; Andrew Menzies; Lucy A Stebbings; Catherine Leroy; Mingming Jia; Richard Rance; Laura J Mudie; Stephen J Gamble; Philip J Stephens; Stuart McLaren; Patrick S Tarpey; Elli Papaemmanuil; Helen R Davies; Ignacio Varela; David J McBride; Graham R Bignell; Kenric Leung; Adam P Butler; Jon W Teague; Sancha Martin; Goran Jönsson; Odette Mariani; Sandrine Boyault; Penelope Miron; Aquila Fatima; Anita Langerød; Samuel A J R Aparicio; Andrew Tutt; Anieta M Sieuwerts; Åke Borg; Gilles Thomas; Anne Vincent Salomon; Andrea L Richardson; Anne-Lise Børresen-Dale; P Andrew Futreal; Michael R Stratton; Peter J Campbell
Journal:  Cell       Date:  2012-05-17       Impact factor: 41.582

5.  Up-regulation of MUC1 in mammary tumors generated in a double-transgenic mouse expressing human MUC1 cDNA, under the control of 1.4-kb 5' MUC1 promoter sequence and the middle T oncogene, expressed from the MMTV promoter.

Authors:  R A Graham; J R Morris; E P Cohen; J Taylor-Papadimitriou
Journal:  Int J Cancer       Date:  2001-05-01       Impact factor: 7.396

6.  The clonal and mutational evolution spectrum of primary triple-negative breast cancers.

Authors:  Sohrab P Shah; Andrew Roth; Rodrigo Goya; Arusha Oloumi; Gavin Ha; Yongjun Zhao; Gulisa Turashvili; Jiarui Ding; Kane Tse; Gholamreza Haffari; Ali Bashashati; Leah M Prentice; Jaswinder Khattra; Angela Burleigh; Damian Yap; Virginie Bernard; Andrew McPherson; Karey Shumansky; Anamaria Crisan; Ryan Giuliany; Alireza Heravi-Moussavi; Jamie Rosner; Daniel Lai; Inanc Birol; Richard Varhol; Angela Tam; Noreen Dhalla; Thomas Zeng; Kevin Ma; Simon K Chan; Malachi Griffith; Annie Moradian; S-W Grace Cheng; Gregg B Morin; Peter Watson; Karen Gelmon; Stephen Chia; Suet-Feung Chin; Christina Curtis; Oscar M Rueda; Paul D Pharoah; Sambasivarao Damaraju; John Mackey; Kelly Hoon; Timothy Harkins; Vasisht Tadigotla; Mahvash Sigaroudinia; Philippe Gascard; Thea Tlsty; Joseph F Costello; Irmtraud M Meyer; Connie J Eaves; Wyeth W Wasserman; Steven Jones; David Huntsman; Martin Hirst; Carlos Caldas; Marco A Marra; Samuel Aparicio
Journal:  Nature       Date:  2012-04-04       Impact factor: 49.962

7.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up.

Authors:  C W Elston; I O Ellis
Journal:  Histopathology       Date:  1991-11       Impact factor: 5.087

8.  Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease.

Authors:  C T Guy; R D Cardiff; W J Muller
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

9.  The landscape of cancer genes and mutational processes in breast cancer.

Authors:  Philip J Stephens; Patrick S Tarpey; Helen Davies; Peter Van Loo; Chris Greenman; David C Wedge; Serena Nik-Zainal; Sancha Martin; Ignacio Varela; Graham R Bignell; Lucy R Yates; Elli Papaemmanuil; David Beare; Adam Butler; Angela Cheverton; John Gamble; Jonathan Hinton; Mingming Jia; Alagu Jayakumar; David Jones; Calli Latimer; King Wai Lau; Stuart McLaren; David J McBride; Andrew Menzies; Laura Mudie; Keiran Raine; Roland Rad; Michael Spencer Chapman; Jon Teague; Douglas Easton; Anita Langerød; Ming Ta Michael Lee; Chen-Yang Shen; Benita Tan Kiat Tee; Bernice Wong Huimin; Annegien Broeks; Ana Cristina Vargas; Gulisa Turashvili; John Martens; Aquila Fatima; Penelope Miron; Suet-Feung Chin; Gilles Thomas; Sandrine Boyault; Odette Mariani; Sunil R Lakhani; Marc van de Vijver; Laura van 't Veer; John Foekens; Christine Desmedt; Christos Sotiriou; Andrew Tutt; Carlos Caldas; Jorge S Reis-Filho; Samuel A J R Aparicio; Anne Vincent Salomon; Anne-Lise Børresen-Dale; Andrea L Richardson; Peter J Campbell; P Andrew Futreal; Michael R Stratton
Journal:  Nature       Date:  2012-05-16       Impact factor: 49.962

Review 10.  Remodeling mechanisms of the mammary gland during involution.

Authors:  Christine J Watson; Peter A Kreuzaler
Journal:  Int J Dev Biol       Date:  2011       Impact factor: 2.203

View more
  14 in total

1.  Cdyl, a new partner of the inactive X chromosome and potential reader of H3K27me3 and H3K9me2.

Authors:  M Escamilla-Del-Arenal; S T da Rocha; C G Spruijt; O Masui; O Renaud; Arne H Smits; R Margueron; M Vermeulen; E Heard
Journal:  Mol Cell Biol       Date:  2013-10-21       Impact factor: 4.272

2.  Single-cell RNA sequencing reveals localized tumour ablation and intratumoural immunostimulant delivery potentiate T cell mediated tumour killing.

Authors:  Ashley R Hoover; Kaili Liu; Christa I DeVette; Jason R Krawic; Alexandra D Medcalf; Connor L West; Tomas Hode; Samuel S K Lam; Alana L Welm; Xiao-Hong Sun; William H Hildebrand; Wei R Chen
Journal:  Clin Transl Med       Date:  2022-07

3.  B-Raf deficiency impairs tumor initiation and progression in a murine breast cancer model.

Authors:  Thomas Reinheckel; Tilman Brummer; Martin Köhler; Sophia Ehrenfeld; Sebastian Halbach; Manuel Lauinger; Ulrike Burk; Nadine Reischmann; Shuofei Cheng; Corinna Spohr; Franziska Maria Uhl; Natalie Köhler; Kathrin Ringwald; Sandra Braun; Christoph Peters; Robert Zeiser
Journal:  Oncogene       Date:  2019-01-18       Impact factor: 8.756

4.  Transformation of enriched mammary cell populations with polyomavirus middle T antigen influences tumor subtype and metastatic potential.

Authors:  Daria Drobysheva; Brittni Alise Smith; Maria McDowell; Katrin P Guillen; Huseyin Atakan Ekiz; Bryan E Welm
Journal:  Breast Cancer Res       Date:  2015-10-01       Impact factor: 6.466

5.  Multipotent luminal mammary cancer stem cells model tumor heterogeneity.

Authors:  Lei Bao; Robert D Cardiff; Paul Steinbach; Karen S Messer; Lesley G Ellies
Journal:  Breast Cancer Res       Date:  2015-10-14       Impact factor: 6.466

Review 6.  Tumor suppression and promotion by autophagy.

Authors:  Yenniffer Ávalos; Jimena Canales; Roberto Bravo-Sagua; Alfredo Criollo; Sergio Lavandero; Andrew F G Quest
Journal:  Biomed Res Int       Date:  2014-09-18       Impact factor: 3.411

7.  Targeting Oncogenes into a Defined Subset of Mammary Cells Demonstrates That the Initiating Oncogenic Mutation Defines the Resulting Tumor Phenotype.

Authors:  Kimberly R Holloway; Vidya C Sinha; Wen Bu; Michael Toneff; Jie Dong; Yi Peng; Yi Li
Journal:  Int J Biol Sci       Date:  2016-02-05       Impact factor: 6.580

8.  Myosin 1e promotes breast cancer malignancy by enhancing tumor cell proliferation and stimulating tumor cell de-differentiation.

Authors:  Jessica L Ouderkirk-Pecone; Gregory J Goreczny; Sharon E Chase; Arthur H Tatum; Christopher E Turner; Mira Krendel
Journal:  Oncotarget       Date:  2016-07-19

9.  Neoplastic transformation of porcine mammary epithelial cells in vitro and tumor formation in vivo.

Authors:  A R Rowson-Hodel; R Manjarin; J F Trott; R D Cardiff; A D Borowsky; R C Hovey
Journal:  BMC Cancer       Date:  2015-07-31       Impact factor: 4.430

10.  The co-factor of LIM domains (CLIM/LDB/NLI) maintains basal mammary epithelial stem cells and promotes breast tumorigenesis.

Authors:  Michael L Salmans; Zhengquan Yu; Kazuhide Watanabe; Eric Cam; Peng Sun; Padhraic Smyth; Xing Dai; Bogi Andersen
Journal:  PLoS Genet       Date:  2014-07-31       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.